Horizon Technology Finance Provides Third Quarter 2021 Portfolio Update
Horizon Technology Finance Corporation (NASDAQ: HRZN) reported strong performance for Q3 2021, achieving a record $141 million in loan originations, with $99 million attributed to HRZN. The portfolio ended with a committed backlog of $123 million, reflecting robust demand for venture loans. During the quarter, HRZN received $50 million in loan prepayments, boosting fee and interest income. The company closed new loan commitments totaling $91 million, with a significant pipeline of opportunities, suggesting ongoing growth potential for shareholders.
- Q3 2021 loan originations reached $141 million, a record for the company.
- HRZN's committed backlog rose to $123 million, indicating strong demand for loans.
- Received $50 million in loan prepayments, enhancing fee income.
- Closed new loan commitments of $91 million during the quarter.
- Decline in committed backlog from $143.5 million in Q2 2021 to $100.6 million by Q3 2021.
FARMINGTON, Conn., Oct. 6, 2021 /PRNewswire/ -- Horizon Technology Finance Corporation (NASDAQ: HRZN) ("HRZN" or the "Company"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and sustainability industries, today provided its portfolio update for the third quarter ended September 30, 2021 and an update on the lending platform ("Horizon Platform") of Horizon Technology Finance Management LLC ("HTFM"), its investment adviser.
"We had an excellent third quarter as the power of the 'Horizon' brand and Horizon's lending platform led to a quarterly record of
"In addition, HRZN received
Third Quarter 2021 Portfolio Update
Originations
During the third quarter of 2021, a total of
$22.5 million to a new portfolio company, Nexii Building Solutions Inc., a green construction technology company focused on creating environmentally-friendly, durable, cost-efficient and disaster-resilient buildings.$15.0 million to an existing portfolio company, Avalo Therapeutics, Inc. (fka Cerecor, Inc.) (NASDAQ: AVTX), a biopharmaceutical company focused on developing and commercializing treatments for immunologic, immuno-oncologic and rare genetic disorders.$15.0 million to an existing portfolio company, TemperPack Technologies, Inc., a manufacturer of sustainable insulated packaging for perishable last mile deliveries.$12.5 million to a new portfolio company, Dropoff, Inc., a same-day delivery service for healthcare and other companies.$7.5 million to a new portfolio company, Stealth BioTherapeutics Inc. (NASDAQ: MITO), a developer of therapies to treat mitochondrial dysfunction associated with genetic mitochondrial diseases and common diseases of aging.$5.0 million to a new portfolio company, Spineology, Inc., a developer of anatomy-conserving technology solutions for use in lumbar spinal fusion procedures.$5.0 million to a new portfolio company, Branded Online, Inc. (dba Nogin), a company offering commerce-as-a-service to consumer and lifestyle brands.$5.0 million to a new portfolio company, RepTrak Holdings, Inc., a developer of data analytics to help companies enhance and protect their corporate reputation.$3.0 million to an existing portfolio company, Primary Kids, Inc., an online baby and children's clothing brand.$2.5 million to a new portfolio company, Embody, Inc., a developer of collagen-based biofabrication techniques and products for sports medicine.$2.5 million to an existing portfolio company, a developer of a software-defined composable infrastructure platform.$2.5 million to a new portfolio company, a developer of plant-based foods.$0.9 million to existing portfolio companies.
Liquidity Events
HRZN experienced liquidity events from five portfolio companies in the third quarter of 2021, including principal prepayments of
- In July, Revinate, Inc. prepaid its outstanding principal balance of
$10.0 million on its venture loan, plus interest, end-of-term payment and prepayment fee. HRZN continues to hold warrants in the company. - In August, Bardy Diagnostics, Inc. was acquired by Hill-Rom Holdings, Inc. and prepaid its outstanding principal balance of
$25.0 million on its venture loan, plus interest, end-of-term payment, prepayment and success fee. HRZN also received proceeds totaling$1.2 million from the redemption of warrants it held in the company. - In September, Silk Technologies, Inc. prepaid its outstanding principal balance of
$9.5 million on its venture loan, plus interest, end-of-term payment and prepayment fee. HRZN continues to hold warrants in the company. - In September, OutboundEngine, Inc. was acquired by Elm Street Technology, LLC and prepaid its outstanding principal balance of
$5.9 million on its venture loan, plus interest, end-of-term payment and prepayment fee. HRZN will receive proceeds totaling$0.3 million from the redemption of warrants it held in the company. - In September, HRZN received a
$0.5 million success fee from its investment in Silkroad Technology, Inc.
Principal Payments Received
During the third quarter of 2021, HRZN received regularly scheduled principal payments on investments totaling
Commitments
During the quarter ended September 30, 2021, HRZN closed new loan commitments totaling
Pipeline and Term Sheets
As of September 30, 2021, HRZN's unfunded loan approvals and commitments ("Committed Backlog"), mostly priced at floating interest rates, were
During the quarter, HTFM received signed term sheets that are in the approval process, which may result in the Horizon Platform providing up to an aggregate of
Capital Markets Activity – Warrant and Equity Portfolio
As of September 30, 2021, HRZN held a portfolio of warrant and equity positions in 75 portfolio companies, including 63 private companies, which provides the potential for future additional returns to HRZN's shareholders.
About Horizon Technology Finance
Horizon Technology Finance Corporation (NASDAQ: HRZN) is a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and sustainability industries. The investment objective of HRZN is to maximize its investment portfolio's return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. Horizon Technology Finance Management LLC is headquartered in Farmington, Connecticut, with a regional office in Pleasanton, California, and investment professionals located in Portland, Maine, Austin, Texas, and Reston, Virginia. To learn more, please visit www.horizontechfinance.com.
Forward-Looking Statements
Statements included herein may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements other than statements of historical facts included in this press release may constitute forward-looking statements and are not guarantees of future performance, condition or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described from time to time in Horizon's filings with the Securities and Exchange Commission. Horizon undertakes no duty to update any forward-looking statement made herein. All forward-looking statements speak only as of the date of this press release.
Contacts:
Investor Relations:
ICR
Garrett Edson
ir@horizontechfinance.com
(860) 284-6450
Media Relations:
ICR
Chris Gillick
HorizonPR@icrinc.com
(646) 677-1819
View original content:https://www.prnewswire.com/news-releases/horizon-technology-finance-provides-third-quarter-2021-portfolio-update-301394564.html
SOURCE Horizon Technology Finance Corporation
FAQ
What were HRZN's loan originations in Q3 2021?
How did HRZN's committed backlog change in Q3 2021?
What is the significance of the loan prepayments received by HRZN?
How much were HRZN's new loan commitments in the latest quarter?